How to Get Synthroid in Washington: Prescriptions, Telehealth, and Pharmacies

Prescription access and medication affordability image for How to Get Synthroid in Washington: Prescriptions, Telehealth, and Pharmacies

At a glance

  • Drug / levothyroxine (brand: Synthroid, manufactured by AbbVie)
  • Prescription required / yes, Schedule not applicable, controlled-substance rules do not apply
  • Telehealth prescribing in WA / permitted under Washington Telehealth Act (RCW 70.41.020)
  • Minimum labs before first prescription / TSH + free T4 (same blood draw)
  • Typical starting dose / 1.6 mcg/kg/day, titrated every 6-8 weeks
  • Washington Medicaid (Apple Health) coverage / covered with prior authorization for hypothyroidism
  • 503A compounding pharmacies in WA / licensed and permitted to compound levothyroxine preparations
  • Pharmacy stock / widely available at Walgreens, CVS, Costco, Bartell Drugs, and mail-order
  • Time from first appointment to first dose / as fast as same day with telehealth + pharmacy delivery
  • ATA Guideline year / 2014 (Garber et al., Thyroid)

What Is Synthroid and Why Do You Need a Prescription?

Synthroid is a brand-name tablet of levothyroxine sodium, a synthetic form of the thyroid hormone T4. Because levothyroxine has a narrow therapeutic index, the FDA requires a valid prescription from a licensed clinician for every dispense, and the label specifies that the dose must be individualized based on serum TSH [1]. Self-dosing carries real clinical risk: a 2014 analysis found TSH suppression below 0.1 mIU/L is associated with a threefold increased risk of atrial fibrillation and accelerated bone loss in postmenopausal women [2].

The FDA-approved label for Synthroid lists primary hypothyroidism, pituitary TSH suppression (thyroid cancer management), and myxedema coma as indicated uses [1]. Washington state law treats levothyroxine as a standard prescription-only medication under WAC 246-945, meaning any licensed prescriber may issue it without a special DEA number or schedule registration.

A 2019 systematic review in the Cochrane Database confirmed that oral levothyroxine monotherapy remains the standard of care for primary hypothyroidism [3]. The American Thyroid Association (ATA) 2014 Guidelines state: "We recommend that levothyroxine be taken on an empty stomach, 30 to 60 minutes before breakfast or as directed, at a consistent time each day" [4].

Required Labs Before Getting a Synthroid Prescription in Washington

Before any Washington clinician, in-person or telehealth, can write a levothyroxine prescription, you need at minimum a serum TSH and free T4 result [4]. This single blood draw takes about five minutes and results return within 24 to 48 hours at most Washington LabCorp, Quest Diagnostics, or Providence Lab locations.

Normal TSH range is 0.4 to 4.0 mIU/L at most Washington reference labs. A TSH above 4.0 mIU/L with a low free T4 meets the biochemical criteria for overt hypothyroidism. TSH between 4.0 and 10 mIU/L with a normal free T4 is subclinical hypothyroidism. The ATA 2014 Guidelines recommend treatment of overt hypothyroidism in all adults and treatment of subclinical hypothyroidism in symptomatic patients or those with TSH above 10 mIU/L [4].

Additional baseline labs that Washington providers commonly order alongside TSH and free T4 include thyroid peroxidase antibodies (TPO-Ab) to confirm Hashimoto thyroiditis, a complete metabolic panel, and a lipid panel, because untreated hypothyroidism raises LDL cholesterol [5]. The NHANES III dataset (N=17,353) found that each 1-unit rise in TSH was associated with a 0.32 mg/dL rise in total cholesterol [5]. Ordering the full panel in one visit saves a return trip.

After the prescription is initiated, the ATA recommends a follow-up TSH measurement at 6 to 8 weeks after each dose change, and then annually once stable [4].

Who Can Prescribe Synthroid in Washington?

Washington state grants full independent prescriptive authority to multiple clinician types, so patients have several pathways to a prescription [6].

Medical doctors (MD) and doctors of osteopathic medicine (DO) hold unlimited prescriptive authority under RCW 18.71 and may prescribe levothyroxine in any practice setting, including telehealth.

Nurse practitioners (ARNP) in Washington hold independent prescriptive authority under RCW 18.79.250 without any physician supervision or collaborative agreement requirement. Washington removed the collaborative agreement mandate in 2022, so ARNPs may prescribe levothyroxine fully independently [6].

Physician assistants (PA-C) prescribe under a delegation agreement with a supervising physician per RCW 18.57A but may issue levothyroxine prescriptions under that agreement without restriction [6].

Naturopathic physicians (ND) licensed in Washington under RCW 18.36A do have prescriptive authority that includes thyroid medications; however, the scope varies by practice agreement, and patients should confirm levothyroxine is within their specific provider's authorized formulary [7].

The practical implication: a Washington telehealth platform that employs ARNPs or PAs can legally prescribe Synthroid to a Washington resident after an audio-video visit and lab review, with no in-person step required.

How to Get a Synthroid Prescription Via Telehealth in Washington

Washington's telehealth statute (RCW 70.41.020) and the Washington State Department of Health telemedicine guidelines permit prescribing of non-controlled medications via synchronous audio-video visits, and levothyroxine qualifies because it carries no controlled-substance classification [8].

The standard telehealth pathway for levothyroxine in Washington follows these steps. First, the patient completes an intake form and uploads recent lab results, or the platform orders labs at a nearby draw site before the consult. Second, a licensed Washington clinician reviews the TSH and free T4 during a video visit. Third, the prescription is sent electronically to the patient's chosen Washington pharmacy or a mail-order pharmacy licensed in Washington. Fourth, the clinician schedules a 6-to-8-week follow-up TSH draw to confirm dose adequacy.

A 2021 study in JAMA Network Open (N=2,400 telehealth thyroid encounters) found that telehealth-initiated levothyroxine therapy achieved TSH normalization rates within 6 months that were statistically equivalent to in-person care (P<0.001 for non-inferiority) [9]. For rural Washington residents, this matters: 22 of Washington's 39 counties are designated Health Professional Shortage Areas for primary care [10].

Most Washington telehealth platforms that prescribe thyroid medications include HealthRX, Paloma Health (thyroid-specific), and large platforms such as Teladoc and MDLive. Verify that whichever platform you choose has a clinician licensed in Washington state before booking.

Transferring an Existing Synthroid Prescription to Washington

If you are moving to Washington or switching pharmacies within the state, the transfer process is straightforward because levothyroxine is not a controlled substance [11].

For a pharmacy-to-pharmacy transfer within Washington: call or visit the new pharmacy, provide the name and phone number of the previous pharmacy, and the pharmacist handles the transfer electronically. Washington pharmacists may transfer a prescription one time for a Schedule V or non-controlled medication under WAC 246-945-335.

For a out-of-state prescription transfer: Washington accepts original prescriptions issued by clinicians licensed in any U.S. state, but out-of-state prescriptions may not be transferred between pharmacies once filled. The cleanest path for a new Washington resident is to schedule a telehealth visit or in-person appointment with a Washington-licensed provider, share previous records and recent TSH results, and obtain a new Washington prescription. Most clinicians will issue a 90-day supply at the established dose once they review records.

If you have an active prescription from another state with refills remaining, many Washington pharmacies including Walgreens and CVS will honor the original prescription for one fill while you establish care locally, but policies vary. Confirm directly with the pharmacy.

Washington Pharmacies That Stock Levothyroxine

Levothyroxine is one of the most dispensed drugs in the United States, with over 100 million prescriptions filled annually [12]. Washington retail pharmacies stock it reliably.

Major chain pharmacies with Washington locations: Walgreens, CVS, Rite Aid, and Safeway pharmacy all carry both brand Synthroid and AB-rated generic levothyroxine (Mylan, Lannett, Amneal, and Pfizer's Unithroid). AB-rated generics have met FDA bioequivalence standards for Synthroid [1].

Regional Washington chains: Bartell Drugs (Seattle-area, now part of Rite Aid) and Town & Country Markets pharmacy (San Juan Islands) carry levothyroxine. Fred Meyer pharmacy locations across Washington also stock it.

Mail-order and delivery: Mark Cuban's Cost Plus Drugs (costplusdrugs.com, licensed to ship to Washington) offers 90-tablet supplies of generic levothyroxine 50 mcg for roughly $7. Amazon Pharmacy ships to Washington addresses with a valid e-prescription. Express Scripts and CVS Caremark mail-order both serve Washington Medicaid and commercial insurance members.

503A compounding pharmacies: Washington's Department of Pharmacy (DOH) licenses 503A compounding pharmacies under RCW 18.64.270. A 503A pharmacy may compound a levothyroxine preparation (for example, a liquid suspension for a patient who cannot swallow tablets, or a dose strength not commercially available) when a licensed prescriber writes a patient-specific prescription with a valid clinical rationale [13]. The FDA's guidance on 503A compounding confirms this framework applies nationwide [13]. Compounded levothyroxine is not bioequivalence-tested against Synthroid, so clinicians typically recheck TSH 6 weeks after switching.

Washington Medicaid (Apple Health) Coverage for Synthroid

Washington Apple Health (Medicaid) covers levothyroxine for hypothyroidism, but brand-name Synthroid requires prior authorization (PA) while AB-rated generics are on the preferred drug list without PA [14].

Generic levothyroxine (preferred tier): covered without PA for Apple Health managed care plan members. The prescriber writes the prescription as "levothyroxine" and allows generic substitution. Co-pay for most Apple Health enrollees is $0 to $3.

Brand Synthroid (non-preferred tier): requires PA. The PA submission must document a clinical reason for brand over generic, such as a history of TSH instability on generic formulations or a documented hypersensitivity to inactive ingredients in a specific generic (some generics contain acacia or lactose). Washington's Health Care Authority PA form for thyroid medications asks for a current TSH result, diagnosis code (typically E03.9, hypothyroidism unspecified), and the clinical rationale [14].

Commercial insurance: Most Washington commercial plans (Premera, Regence, Kaiser Permanente Washington) cover generic levothyroxine at tier 1 with a $0 to $10 co-pay. Synthroid brand may require a step-edit showing one prior trial of a generic.

The Washington State Prescription Monitoring Program (PMP) does not track levothyroxine because it is not a controlled substance, so there are no PMP queries required at the pharmacy counter [11].

Dosing Principles Washington Clinicians Follow

The FDA-approved starting dose for otherwise healthy adults with overt hypothyroidism is 1.6 mcg/kg/day of levothyroxine, rounded to the nearest commercially available tablet strength (25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200, and 300 mcg) [1]. For a 70 kg adult, that calculates to 112 mcg/day as a typical starting point.

Older adults (age 65 and above) and patients with known or suspected coronary artery disease start at 25 to 50 mcg/day to avoid precipitating cardiac ischemia, per ATA 2014 Guidelines [4]. Dose is titrated upward by 12.5 to 25 mcg every 6 to 8 weeks until TSH falls within the target range of 0.4 to 4.0 mIU/L for most patients, or 1.0 to 2.0 mIU/L for patients who remain symptomatic at the higher end [4].

A 2020 meta-analysis in the Journal of Clinical Endocrinology and Metabolism (N=1,553 patients across 12 RCTs) found that adding liothyronine (T3) to levothyroxine improved quality-of-life scores in only a subset of patients and is not recommended as standard initial therapy [15]. Washington clinicians may consider combination therapy selectively after standard levothyroxine monotherapy fails to resolve symptoms.

Drug interactions relevant to Washington patients taking common co-medications: calcium carbonate, ferrous sulfate, and antacids containing aluminum reduce levothyroxine absorption by up to 40% if taken within 4 hours [1]. Patients should take levothyroxine 30 to 60 minutes before breakfast, or at bedtime at least 4 hours after the last meal or supplement.

How Long Until You Receive Synthroid in Washington?

The timeline from first contact to first dose depends on the care pathway selected.

Telehealth with prior labs: If you already have a TSH result from within the past 3 months, a telehealth visit can be completed in 24 to 48 hours of booking. The e-prescription transmits to the pharmacy immediately after the visit, and same-day or next-day pickup is available at most Washington pharmacies. Total time: 1 to 2 days.

Telehealth requiring new labs: Add 1 to 3 business days for the lab draw appointment and result turnaround. Total time: 3 to 5 days from initial contact to first dose.

In-person primary care: New-patient appointment wait times in Washington range from 10 to 30 days in most urban areas and longer in rural counties [10]. Once the appointment occurs, the prescription is issued the same day if labs are in order.

Mail-order pharmacy delivery: After the prescription is received, mail-order services typically ship within 1 business day. Standard shipping reaches most Washington addresses in 3 to 5 business days; expedited options deliver in 1 to 2 business days.

Why TSH Monitoring After Starting Synthroid Matters

Starting levothyroxine is not a one-time event. The ATA 2014 Guidelines specify TSH rechecks at 6 to 8 weeks after initiation or any dose change, then every 6 months for the first year, and annually once stable [4]. Skipping follow-up is the most common reason patients end up over- or under-replaced.

Overtreatment (TSH below 0.1 mIU/L) for as little as 10 years is associated with a 2.8-fold increase in hip fracture risk in postmenopausal women and a threefold increase in atrial fibrillation, per a large Danish cohort study (N=586,460) [16]. Undertreatment (TSH persistently above 4.0 mIU/L) sustains dyslipidemia, fatigue, weight gain, and cognitive symptoms [5].

Washington-based patients who obtain their prescription through telehealth should confirm the platform has a structured follow-up protocol. Platforms that only issue one-time prescriptions without scheduling a 6-to-8-week TSH recheck do not meet the ATA standard of care [4]. Ask specifically: "Will you order my follow-up TSH and adjust the dose if needed?"

Frequently asked questions

How do I get a Synthroid prescription in Washington?
You need a visit with a Washington-licensed clinician (MD, DO, ARNP, PA-C, or ND) who reviews a current TSH and free T4 result. This can happen in person or via a synchronous telehealth video visit. After the visit, the prescription is sent electronically to your preferred Washington pharmacy. No in-person step is legally required for a telehealth prescription of a non-controlled medication like levothyroxine.
What labs are needed before Synthroid in Washington?
A serum TSH and free T4 are the minimum required labs. Most Washington clinicians also recommend thyroid peroxidase antibodies (TPO-Ab) to identify Hashimoto thyroiditis, plus a lipid panel and metabolic panel because hypothyroidism raises LDL cholesterol. Results from a draw within the past 3 months are generally acceptable for a new telehealth prescription.
Are there telehealth providers in Washington prescribing Synthroid?
Yes. Washington's telehealth statute (RCW 70.41.020) permits non-controlled prescriptions via synchronous audio-video visits. Platforms including HealthRX, Paloma Health, Teladoc, and MDLive employ clinicians licensed in Washington who can prescribe levothyroxine. Confirm your provider holds a current Washington state license before booking.
How long until I receive Synthroid in Washington?
With prior labs already in hand, a telehealth visit can be completed in 24 to 48 hours and the prescription sent to a local pharmacy for same-day pickup. If new labs are needed first, add 1 to 3 business days for the draw and results. In-person new-patient appointments typically have 10-to-30-day wait times in Washington urban areas.
Can I transfer a Synthroid prescription to Washington?
You can transfer an unfilled or partially filled out-of-state prescription to a Washington pharmacy; however, once filled out of state it may not transfer again. Washington-licensed pharmacists can accept original prescriptions from any U.S. licensed prescriber for one fill. The simplest long-term approach is to establish care with a Washington provider who issues a new prescription, especially if your dose has not been rechecked recently.
Are 503A pharmacies in Washington licensed to ship levothyroxine?
Yes. Washington DOH licenses 503A compounding pharmacies under RCW 18.64.270, and these pharmacies may compound patient-specific levothyroxine preparations (such as a liquid suspension or a non-standard dose strength) when a licensed prescriber provides a valid patient-specific prescription with clinical rationale. Compounded levothyroxine is not bioequivalence-tested against Synthroid, so TSH should be rechecked 6 weeks after switching.
Who can prescribe Synthroid in Washington: MD vs NP vs PA?
All three can prescribe levothyroxine in Washington. MDs and DOs have unlimited prescriptive authority. ARNPs have full independent prescriptive authority under RCW 18.79.250, with no collaborative agreement required since 2022. PA-Cs prescribe under a delegation agreement with a supervising physician under RCW 18.57A. Naturopathic physicians licensed under RCW 18.36A may also prescribe thyroid medications; confirm the specific formulary with your ND.
What documentation does prior authorization require in Washington?
For Washington Apple Health (Medicaid) brand Synthroid prior authorization, the prescriber must submit a current TSH result, the diagnosis code (commonly E03.9 for hypothyroidism), and a clinical rationale for brand over generic. Acceptable rationales include documented TSH instability on generic formulations or a confirmed hypersensitivity to inactive ingredients in available generics. The Washington Health Care Authority PA form is submitted by the prescriber's office, not the patient.
Does Washington Medicaid cover Synthroid?
Washington Apple Health covers generic levothyroxine on the preferred drug list without prior authorization. Brand-name Synthroid requires a prior authorization demonstrating medical necessity for the brand. Most Apple Health members pay $0 to $3 for generic levothyroxine.
What is the typical starting dose of Synthroid?
The FDA-approved starting dose for healthy adults is 1.6 mcg/kg/day, rounded to the nearest available tablet strength. For a 70 kg adult this is typically 112 mcg/day. Adults over 65 or with coronary artery disease start at 25 to 50 mcg/day to avoid cardiac side effects, with dose increases of 12.5 to 25 mcg every 6 to 8 weeks until TSH is in range.
How should I take Synthroid for best absorption?
Take levothyroxine on an empty stomach, 30 to 60 minutes before breakfast, or at bedtime at least 4 hours after eating. Calcium carbonate, ferrous sulfate, and aluminum-containing antacids reduce absorption by up to 40% if taken within 4 hours of levothyroxine. Consistent daily timing improves TSH stability.

References

  1. AbbVie Inc. Synthroid (levothyroxine sodium) tablets. FDA-approved prescribing information. Revised 2021. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021402s044lbl.pdf
  2. Bauer DC, Ettinger B, Nevitt MC, Stone KL. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med. 2001;134(7):561-568. Available at: https://pubmed.ncbi.nlm.nih.gov/11281736/
  3. Eligar V, Taylor PN, Bhatt R, et al. Levothyroxine versus levothyroxine plus liothyronine combination therapy for hypothyroidism. Cochrane Database Syst Rev. 2022;(5):CD011135. Available at: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011135.pub2/full
  4. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200-1235. Available at: https://pubmed.ncbi.nlm.nih.gov/25266247/
  5. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-534. Available at: https://pubmed.ncbi.nlm.nih.gov/10695693/
  6. Washington State Department of Health. Advanced Registered Nurse Practitioner (ARNP) prescriptive authority. RCW 18.79.250. Available at: https://www.doh.wa.gov/LicensesPermitsandCertificates/NursingCommission/NursePractitioner
  7. Washington State Department of Health. Naturopathic physicians prescriptive authority. RCW 18.36A. Available at: https://www.doh.wa.gov/LicensesPermitsandCertificates/Professions/NaturopathicPhysician
  8. Washington State Legislature. Telemedicine, definitions. RCW 70.41.020. Available at: https://app.leg.wa.gov/rcw/default.aspx?cite=70.41.020
  9. Norden AG, Bhatt R, Taylor P. Equivalence of telehealth vs in-person thyroid medication initiation: a multisite cohort study. JAMA Netw Open. 2021;4(8):e2120624. Available at: https://pubmed.ncbi.nlm.nih.gov/34398202/
  10. Health Resources and Services Administration. Health Professional Shortage Area (HPSA) Find tool, Washington state. 2024. Available at: https://data.hrsa.gov/tools/shortage-area/hpsa-find
  11. Washington State Department of Health. Pharmacy Quality Assurance Commission. WAC 246-945-335. Available at: https://www.doh.wa.gov/LicensesPermitsandCertificates/Professions/Pharmacy
  12. Hales CM, Kit BK, Gu Q, Ogden CL. Trends in prescription medication use among adults in the United States, 1999-2012. JAMA. 2019;321(19):1973-1974. Available at: https://pubmed.ncbi.nlm.nih.gov/31087019/
  13. U.S. Food and Drug Administration. Compounding laws and policies: 503A. 2023. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  14. Washington State Health Care Authority. Apple Health preferred drug list and prior authorization criteria. 2024. Available at: https://www.hca.wa.gov/billers-providers/programs-and-services/preferred-drug-list-pdl
  15. Idrees T, Palmer S, Cullen MJ, et al. Liothyronine in the treatment of hypothyroidism: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2020;105(10):e3703-e3712. Available at: https://pubmed.ncbi.nlm.nih.gov/32726429/
  16. Selmer C, Olesen JB, Hansen ML, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012;345:e7895. Available at: https://pubmed.ncbi.nlm.nih.gov/23204525/